In a screening test involving a lot more than 240 receptors, the researchers uncovered that conolidine demonstrated binding on the ACKR3 receptor in each humans and mice, protecting against ACKR3 from binding to opioid peptides. Conolidine CONOCB2™, which has been code-named 'nature